H. R. Arvate, “Major clinical outcomes of the action of the co-agonist tirzepatide to liraglutide and semaglutide in the treatment of obesity and type 2 diabetes mellitus: a systematic review”, IJN, vol. 18, no. 1, Jan. 2025.